IL-23R-Specific Chimeric Antigen Receptor Tregs in Crohn's Disease: Dawn of a Cellular Immunotherapeutic Era?

J Crohns Colitis. 2025 Apr 4;19(4):jjae159. doi: 10.1093/ecco-jcc/jjae159.

Authors

Raja Atreya^{1

2}, Markus F Neurath^{1

2}

Affiliations

¹ Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
² Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany.

PMID: 39432833
DOI: 10.1093/ecco-jcc/jjae159

No abstract available

Publication types

Editorial
Comment